Novartis, one of the world’s largest pharmaceutical companies, has executed an agreement to sell one of Sandoz Turkey’s manufacturing facilities in Gebze to Generica İlaç, a Turkish company engaged in the manufacturing, marketing and sale of pharmaceutical products since 2007. The transaction includes the transfer of all associated assets and employees of Sandoz Turkey on the Gebze site. The deal is expected to close by mid-2020 subject to obtaining the necessary approvals from regulatory authorities, including the Competition Board, the Gebze Plastic Manufacturers Organized Industrial Zone and the Ministry of Industry and Technology. After closing, Generica İlaç will continue to manufacture and supply certain products to Novartis.
Paksoy is pleased to announce that Elvan Aziz (partner), Nazlı Bezirci (counsel) and Gözde Zorlu (associate) are advising Novartis on this transaction.
Share
Related persons
You can contact us for detailed information.
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
8 November 2024
Paksoy advises General Atlantic on USD 500 million Series E investment in Insider as local counsel
Insider, a software company specializing in AI-powered customer experience and customer engagement is set to receive USD 500 million in its…
24 October 2024
Paksoy advises Korean consortium on landmark investment in Nakkaş-Başakşehir section on Northern Marmara Highway Project
The financial signing ceremony for the Nakkaş-Başakşehir section of the Northern Marmara Highway Project was held on 18 October 2024. The…
24 October 2024
Paksoy advises Türkiye Wealth Fund on its inaugural sukuk issuance
We are proud to be a part of the USD 750 million inaugural sukuk issuance of Türkiye Wealth Fund. Congratulations to the Türkiye Wealth…
22 October 2024
Paksoy advises ADQ on the acquisition of Odea Bank
Abu Dhabi’s USD 249 billion sovereign wealth fund ADQ announced on 15 October 2024 that it had signed a share purchase agreement to acquire…
16 October 2024
Paksoy advised Rönesans Holding’s $350 million sustainable Eurobond offering
We are glad to have completed another important capital markets transaction.
2 October 2024
Paksoy advises Global Payments on the acquisition of Yazara and its Turkish subsidiary SoftPos
Global Payments Inc., a global leader of payment technology systems has closed the acquisition of Yazara Payment Solutions Inc., an…